"However," she adds, "these savings are often not shared with patients whose out-of-pocket costs continue to soar." Raising drug prices affects everyone When prices go up, it doesn't just affect Americans without coverage. It can have much broader ramifications. "Rising drug prices affect un...
The article offers the authors' response to Rena Conti, associate professor in the Departments of Pediatrics and Public Health Sciences at the University of Chicago, Illinois, regarding the concept of Medicare price negotiations for rising prescription drug spending in the U.S. They comment on ...
Individual advocacy groups that stay silent on high drug prices may nonetheless think they are doing the best they can for patients in a world where pharmaceutical companies have so much power. Each group on its own lacks the power to win structural reforms, so they settle for trying to ge...
And prescription drug prices are rising even faster than general health care costs. A recently published report found that prescription drug prices increased at an annual rate of 8.3% from 2006 through the beginning of 2010, significantly faster than the 3.8% annual increase in overall health care...
But lawmakers and the public alike are in an uproar over prescription drug prices. Drug costs poll at the top of voters’ health care concerns, and the issue has been reflected both on the campaign trail and in congressional hearings.
Rise of prescription drug costs Americans pay an average of abouttwice as much for prescription drugsas those and other modern nations. The high cost of drugs is largely accountable for rising health care expenses in the country. In Europe, the government regulates drug prices based on...
The economics of prescription drug prices, government intervention, and the importation of drugs from Canada. Popular attention has focused on the skyrocketing health care costs in the United States and specifically on increasing insurance and prescription drug pri... MS Openshaw - 《Nursing Economic...
Investment funds increasingly see the healthcare sector as an attractive investment opportunity and are viewed as influencing rising prices, according to the Harvard Business Review.19Private equity has a growing presence in the health sector, says Institutional Investor.20Firms are investing in pharma,...
The prescription drug market provides a microcosm of the issue. Patents for new drugs are granted to allow innovative firms to charge high prices and thus encourage innovation. However, when patents are combined with insurance, the resulting prices can be exorbitant. Insurers, in an effort to cou...
Arthur J. Goldberg Distinguished Professor of Law at UC Hastings College of Law San Francisco, tells Verywell. She also noted that we are "...going to need some systemic changes to try to address the problems that are driving drug prices higher in general, and insulin prices higher specifica...